Journal
FRONTIERS IN IMMUNOLOGY
Volume 10, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2019.00210
Keywords
5hmC; 5 hydroxymethylcytosine; ten eleven translocation (TET); DNA modification; epigenetics (methylation/demethylation); gene regulation and expression
Categories
Funding
- NIH [R35 CA210043, AI109842, AI128589]
- Translation Research Project grants from the Leukemia and Lymphoma Society [6187-12, 6464-15]
- Independent Investigator Fund (Kyowa Hakko Kirin/La Jolla Institute)
- Irvington Postdoctoral Fellowship from the Cancer Research Institute
Ask authors/readers for more resources
DNA methylation is an abundant and stable epigenetic modification that allows inheritance of information from parental to daughter cells. At active genomic regions, DNA methylation can be reversed by TET (Ten-eleven translocation) enzymes, which are responsible for fine-tuning methylation patterns. TET enzymes oxidize the methyl group of 5-methylcytosine (5mC) to yield 5-hydroxymethylcytosine (5hmC) and other oxidized methylcytosines, facilitating both passive and active demethylation. Increasing evidence has demonstrated the essential functions of TET enzymes in regulating gene expression, promoting cell differentiation, and suppressing tumor formation. In this review, we will focus on recent discoveries of the functions of TET enzymes in the development and function of lymphoid and myeloid cells. How TET activity can be modulated by metabolites, including vitamin C and 2-hydroxyglutarate, and its potential application in shaping the course of immune response will be discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available